Cannabis sativa L. protects against oxidative injury in kidney (vero) cells by mitigating perturbed metabolic activities linked to chronic kidney diseases

Keyphrases

• Chronic Kidney Disease 100%
• Oxidative Damage 100%
• Cannabis Sativa 100%
• Metabolic Activity 100%
• Sativa 100%
• Kidney 100%
• Vero Cells 100%
• FeSO4 60%
• Oxidative Stress 40%
• MTT Assay 40%
• Purinergic 40%
• Glucogenic 40%
• Redox Balance 20%
• Dysregulated 20%
• Medicinal Plants 20%
• Traditional Medicine 20%
• Protective Effect 20%
• Ailments 20%
• Kidney Disease 20%
• High Concentration 20%
• Enzyme Activity 20%
• Dichloromethane 20%
• Negative Control 20%
• Ethanol 20%
• Hexane 20%
• ATP Synthase 20%
• Catalase Activity 20%
• Ethnopharmacological Relevance 20%
• Fructose 20%
• Protection Potential 20%
• Acetylcholinesterase 20%
• Glucose-6-phosphatase (G6Pase) 20%
• Vero Cell Line 20%
• Glutathione Level 20%
• Malondialdehyde Level 20%
• Glycogen Phosphorylase 20%
• Renal Injury 20%
• Sequential Extract 20%
• ENTPD1 20%
• 6-bisphosphatase 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Cannabis Sativa 100%
• Kidney Disease 100%
• Dichloromethane 50%
• Glutathione 50%
• Catalase 50%
• Acetylcholinesterase 50%
• Adenosine Triphosphatase 50%
• Hexane 50%
• Enzymes 50%
• Malonaldehyde 50%
• Cholinergic Receptor Stimulating Agent 50%
• Glucose 6 Phosphatase 50%
• Medicinal Plant 50%
• Fructose Bisphosphatase 50%
• Glycogen Phosphorylase 50%
• Kidney Injury 50%
• Ethanol 50%

Biochemistry, Genetics and Molecular Biology

• Extract 100%
• Cannabis Sativa 100%
• MTT Assay 50%
• Oxidative Stress 50%
• Medicinal Plant 25%
• Catalase 25%
• Enzyme Activity 25%
• ATPase 25%
• Acetylcholinesterase 25%
• Dichloromethane 25%
• Glucose 6-Phosphatase 25%
• Fructose 1,6-bisphosphatase 25%
• Glutathione 25%
• Cholinergic 25%
• Glycogen Phosphorylase 25%